For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo Group | placebo: Subjects will receive daily dosing at night with caplets matching the appearance of the active drug. However, caplets will not contain any active medication. | None | None | 0 | 13 | 5 | 13 | View |
| Quietapine Group | quetiapine SR: Subjects will receive daily dosing at night, with a flexible dosing schedule, 50-400 mg. | None | None | 0 | 13 | 10 | 13 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Somnolence | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Anxiety | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Dry Mouth | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Restlessness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Derealization | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Insomnia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Increased Appetite | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Leg Pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Weight Loss | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Shakiness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Muscle Aches | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Weight Gain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |